What does this research mean for the field?

MCT1 contributes to cancer progression through both its established role in plasma membrane metabolite transport and its emerging, though insufficiently validated, involvement in nuclear localization and metabolite-driven epigenetic regulation. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Synthesize established transport functions of monocarboxylate transporter 1 (MCT1) with emerging evidence on its nuclear localization and metabolic-epigenetic crosstalk in cancer.

August 22, 2026CancersOpen Access

Monocarboxylate Transporter 1 (MCT1) in Cancer Biology: Canonical Transport Functions, Metabolic–Epigenetic Crosstalk and Emerging Nuclear Localisation

View Full Paper

Ask AI

Bookmark

Authors

JFJakub FranczakUniversity of Manchester ALAyşe LatifNational Health Service Scotland

Discussion

Member takes

Implication

Review outlines monocarboxylate transporter 1 metabolic functions and emerging nuclear roles in cancer, highlighting opportunities for targeted therapeutics.

Key Points

Synthesize established transport functions of monocarboxylate transporter 1 (MCT1) with emerging evidence on its nuclear localization and metabolic-epigenetic crosstalk in cancer.
Reviewed literature regarding SLC16A1/MCT1 transport mechanisms across various malignancies and immune contexts.
Analyzed mechanistic evidence linking MCT1-transported substrates to chromatin state, histone modifications, and gene regulation.
Evaluated reported observations and experimental validation gaps concerning nuclear or nuclear-associated MCT1 localization.
Plasma membrane MCT1 drives cancer progression by mediating proton-coupled transport of lactate, pyruvate, and ketone bodies, contributing to metabolic symbiosis, angiogenesis, immune evasion, and therapy resistance.
MCT1 substrates modulate chromatin state through direct and indirect metabolic-epigenetic mechanisms, influencing gene expression via histone alterations.
Putative nuclear MCT1 localization has been detected in cancer and immune settings, though its direct functional roles currently require rigorous orthogonal validation.

Cite This Study

Franczak et al. (2026) studied this question.

synapsesocial.com/papers/6a89600eca7ade938187f0e5 https://doi.org/10.3390/cancers18162699

View Full Paper

Ask AI

Bookmark

Implication

Review outlines monocarboxylate transporter 1 metabolic functions and emerging nuclear roles in cancer, highlighting opportunities for targeted therapeutics.

Monocarboxylate Transporter 1 (MCT1) in Cancer Biology: Canonical Transport Functions, Metabolic–Epigenetic Crosstalk and Emerging Nuclear Localisation

Discussion

Member takes

Implication

Key Points

Cite This Study

Monocarboxylate Transporter 1 (MCT1) in Cancer Biology: Canonical Transport Functions, Metabolic–Epigenetic Crosstalk and Emerging Nuclear Localisation

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider